Canaccord Genuity Maintains Buy on AdaptHealth, Raises Price Target to $16

ADAPTHEALTH CORP

ADAPTHEALTH CORP

AHCO

0.00

Canaccord Genuity analyst Richard Close maintains AdaptHealth (NASDAQ: AHCO) with a Buy and raises the price target from $14 to $16.